Prices are updated after-hours

Ireland

Nabriva Therapeutics plc

NBRV | $1.42 1.39% 720K

(0.0% 1d) (0.0% 1m) (-12.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (3702.73% volume)
Earnings Calendar: 2023-08-03
Market Cap: $ 4,546,068
http://www.nabriva.com
Sec Filling | Patents | 162 employees

(IE) Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland.

antibiotics pleuromutilin antibiotic antibacterial injection

add to watch list Paper trade email alert is off

Mallinckrodt plc

MNKKQ | $0.02

Manufacturing

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (10.5% 3d) (0.0% 7d) (-51.93% volume)
Earnings Calendar:
Market Cap:
http://www.mallinckrodt.com/
Sec Filling | Patents | 3085 employees

(IE) Mallinckrodt Pharmaceuticals is an Irish–tax registered manufacturer of specialty pharmaceuticals , generic drugs and imaging agents. In 2017 it generated 90% of sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversion to Ireland drew controversy when it was shown Acthar, was Medicaid's most expensive drug. Mallinckrodt acquires , manufactures, and distributes products used in diagnostic procedures and in the treatment of pain and related conditions. This includes the acquisition, manufacture, and distribution of specialty pharmaceuticals, active pharmaceutical ingredients, contrast products, and radiopharmaceuticals. The company employed 5,500 and had net sales of $3.2 billion in 2017; of which $2.9 billion was from the U.S. healthcare system.

diagnostics acquisitions treatment

add to watch list Paper trade email alert is off

CRH PUBLIC LTD CO

CRHCF | $53.562 -24.62% 140

Non-Energy Minerals

(0.0% 1d) (0.0% 1m) (11.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-72.89% volume)
Earnings Calendar:
Market Cap: $ 38,831,893,330
http://www.crh.com
Sec Filling | Patents | n/a employees

(IE) CRH Plc manufactures and distributes building materials and products for the construction industry. It operates business through the following segments: Europe Heavyside, Lightside, and Distribution; Americas Materials and Products and Asia. The Europe Heavyside and Americas Materials segments produce and sell primary materials, including cement, aggregates, ready mixed concrete, asphalt, agricultural and chemical lime. The Europe Lightside segment is involved in the production and sale of architectural, structural concrete products, clay products, insulation products, fabricated & tempered glass products, construction accessories and the provision of inter related products and services to the construction sector. The Europe Distribution segment includes the businesses of builder's merchandising activities. The Americas Products segment manufactures and supplies construction products. The Asia segment is comprised of cement operations in Philippines, Northeast China and Southern India. The company was founded in 1970 and is headquartered in Rathfarnham, Ireland.

agricultural agriculture construction insulation

add to watch list Paper trade email alert is off

RYANAIR HOLDINGS PLC

RYAOF | $20.41 -33.4% 100

Transportation

(0.0% 1d) (0.0% 1m) (15.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-52.38% volume)
Earnings Calendar:
Market Cap: $ 30,442,059,641
http://www.ryanair.com
Sec Filling | Patents | n/a employees

(IE) Ryanair Holdings Plc engages in the provision of low fares airline-related services. It includes scheduled services, internet, and other related services to third parties across a European route network. It also offers various ancillary services, and other activities connected with its core air passenger service, as well as non-flight scheduled services, internet-related services, and the in-flight sale of beverages, food, and merchandise. The company was founded on June 5, 1996 and is headquartered in Dublin, Ireland.

add to watch list Paper trade email alert is off

Mallinckrodt plc

MNK | $0.3402 -0.06% 540K

n/a

(0.0% 1d) (1.8% 1m) (-93.2% 1y) (0.0% 2d) (-16.6% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 4,520,979
http://mallinckrodt.com
Sec Filling | Patents | 3400 employees

(IE) Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.

brands

add to watch list Paper trade email alert is off

Nabriva Therapeutics plc

NBRVF | $0.0002 -50.0% 330

n/a

(0.0% 1d) (0.0% 1m) (-100.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-55.53% volume)
Earnings Calendar:
Market Cap: $ 6,462
https://www.nabriva.com/
Sec Filling | Patents | 66 employees

(IE) nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a focus on the pleuromutilin class of antibiotics. our goal is to become a fully integrated biopharmaceutical company focused on the research, development and commercialization of novel anti-infective products. nabriva was incorporated as a spin-off from sandoz gmbh antibiotics research institute (abri) in vienna, austria and commenced operations in february 2006. the new organization included small molecule assets, including pleuromutilin structure activity relationships (sar) knowledge and was focused on synthesis of pleuromutilins for systemic human use. following identification of our lead compound lefamulin and based on the clinical results of lefamulin for acute skin and skin structure infections. we believed that targeted in vitro spectrum of activity for the common pathogens causing community acquired bacterial pneumonia (cabp), wo

pathogens

add to watch list Paper trade email alert is off

Mallinckrodt plc

MNKTQ | $0.12 -66.67% 39K

Manufacturing

(0.0% 1d) (0.0% 1m) (-36.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-97.94% volume)
Earnings Calendar:
Market Cap: $ 1,594,702
http://www.mallinckrodt.com/
Sec Filling | Patents | 3046 employees

(IE) mallinckrodt is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and central nervous system drugs. the company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. the company's specialty brands segment includes branded medicines; its specialty generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing; and the global medical imaging segment includes contrast media and nuclear imaging agents. to learn more about mallinckrodt, visit

add to watch list Paper trade email alert is off

Mallinckrodt plc

MNKPF | $17.25

n/a

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (186.25% volume)
Earnings Calendar:
Market Cap: $ 0
http://www.mallinckrodt.com/
Sec Filling | Patents | 3085 employees

(IE)

add to watch list Paper trade email alert is off

Aercap Holdings N.V.

AER | $83.59 1.27% 0.0% 1.8M

Finance

(0.0% 1d) (-3.6% 1m) (47.9% 1y) (0.0% 2d) (0.0% 3d) (-0.6% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-23
Market Cap: $ 16,545,129,109
http://www.aercap.com
Sec Filling | Patents | 390 employees

(IE) AerCap Holdings NV engages in aircraft leasing and aviation finance. The firm also provides aircraft owners, financiers and investors with asset services to manage an aircraft portfolio. It operates through leasing, financing, sales, and management of commercial aircraft and engines segment. The company was founded in 1995 and is headquartered in Dublin, Ireland.

add to watch list Paper trade email alert is off

Amarin Corporation plc

AMRN | News | $0.9249 3.24% 3.14% 880K

Health Technology

(0.0% 1d) (7.1% 1m) (-33.6% 1y) (0.0% 2d) (3.7% 3d) (-5.2% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 91,381,953
http://amarincorp.com
Sec Filling | Patents | 965 employees

(IE) Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

cardiovascular marine vascepa

add to watch list Paper trade email alert is off

Avadel Pharmaceuticals plc

AVDL | $17.98 -0.61% -0.61% 1.6M

Health Technology

(0.0% 1d) (14.5% 1m) (78.4% 1y) (0.0% 2d) (0.0% 3d) (13.1% 7d) (57.99% volume)
Earnings Calendar:
Market Cap: $ 0
http://www.avadel.com
Sec Filling | Patents | 50 employees

(IE) Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

ft218 narcolepsy

add to watch list Paper trade email alert is off

Cimpress PLC

CMPR M | $90.135 0.71% 0.7% 110K

Commercial Services

(0.0% 1d) (-0.4% 1m) (104.9% 1y) (0.0% 2d) (0.0% 3d) (-4.0% 7d) (-17.97% volume)
Earnings Calendar: 2023-07-26
Market Cap: $ 2,400,889,130
http://cimpress.com
Sec Filling | Patents | 13000 employees

(IE) Cimpress Plc invests in and builds entrepreneurial and mass-customization businesses. Its business includes BuildASign, Drukwerkdeal, Exaprint, National Pen, Pixartprinting, Printi, Vistaprint and WIRmachenDRUCK. The company was founded by Robert S. Keane in January 1995 and is headquartered in Dundalk, Ireland.

add to watch list Paper trade email alert is off

Endo International plc

ENDPQ | $0.004 -50.0% 1.7M

n/a

(0.0% 1d) (1233.3% 1m) (-94.1% 1y) (0.0% 2d) (0.0% 3d) (1233.3% 7d) (299.89% volume)
Earnings Calendar: 2022-11-03
Market Cap: $ 940,878
https://www.endo.com
Sec Filling | Patents | 3397 employees

(IE) Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.

treatment

add to watch list Paper trade email alert is off

Experian Group LTD

EXPGF | $40.98 -16.52% 200

n/a

(0.0% 1d) (-6.1% 1m) (18.3% 1y) (0.0% 2d) (0.0% 3d) (-1.0% 7d) (2.56% volume)
Earnings Calendar:
Market Cap: $ 37,645,982,518
http://www.experianplc.com
Sec Filling | Patents | 11000 employees

(IE) Experian Plc is a global information services company, which engages in the provision of data and analytical tools that are used to manage credit risk, prevent fraud, target marketing offers, and automate decision making. Its activities are grouped into four global business lines: Credit Services, Decision Analytics, Marketing Services, and Consumer Services. The Credit Services provides information to organizations to help manage the risks associated with extending credit and preventing fraud. The Decision Analytics unlocks the value of its vast store of credit and marketing information, as well as other data sources, by applying expert consulting, analytical tools and software to convert data into valuable business decisions. The Marketing Services helps many of the organizations target and engage to customers through sophisticated marketing strategies that generate significant return on investment. The Consumer Services provides credit monitoring services to millions of consumers via the internet. The company was founded by John Wilfred Peace in 1980 and is headquartered in Dublin, Ireland.

add to watch list Paper trade email alert is off

Experian Group LTD

EXPGY | $40.72 0.17% 43K

n/a

(0.0% 1d) (-4.1% 1m) (20.2% 1y) (0.0% 2d) (0.0% 3d) (-0.7% 7d) (-12.39% volume)
Earnings Calendar:
Market Cap: $ 37,417,384,081
https://www.experianplc.com/
Sec Filling | Patents | 3 employees

(IE) immix biopharma's mission is to develop novel and game-changing cancer therapies. . .

add to watch list Paper trade email alert is off

GH Research PLC

GHRS | $11.02 0.27% 0.27% 78K

Manufacturing

(0.0% 1d) (0.9% 1m) (30.8% 1y) (0.0% 2d) (0.0% 3d) (-1.8% 7d) (112.16% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 573,350,158
https://www.ghres.com
Sec Filling | Patents | 2021 employees

(IE) GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.

treatment

add to watch list Paper trade email alert is off

ICON plc

ICLR | $291.85 -0.74% -0.75% 390K

Health Technology

(0.0% 1d) (-12.8% 1m) (38.7% 1y) (0.0% 2d) (-0.7% 3d) (-4.6% 7d) (-42.16% volume)
Earnings Calendar:
Market Cap: $ 24,076,190,849
http://www.iconplc.com
Sec Filling | Patents | 14650 employees

(IE) ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

msa

add to watch list Paper trade email alert is off

Jazz Pharmaceuticals plc

JAZZ | News | $107.15 -1.61% -1.63% 590K

Health Technology

(0.0% 1d) (-14.3% 1m) (-26.2% 1y) (0.0% 2d) (-1.7% 3d) (-3.1% 7d) (8.63% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 6,750,450,000
http://www.jazzpharma.com
Sec Filling | Patents | 1620 employees

(IE) Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

urea narcolepsy msa

Drugs

DEFITELIO (defibrotide sodium)
ERWINAZE (Asparaginase)
FazaClo (clozapine)
Prialt (ziconotide)
SUNOSI (solriamfetol)
VYXEOS ((daunorubicin and cytarabine) liposome)
Xyrem (sodium oxybate)
XYWAV ((calcium, magnesium, potassium, and sodium oxybates))
ZEPZELCA (Lurbinectedin)

add to watch list Paper trade email alert is off

Johnson Controls International plc

JCI | News F | $63.69 -0.84% 0.0% 3.9M

Producer Manufacturing

(0.0% 1d) (-0.1% 1m) (8.2% 1y) (0.0% 2d) (-0.8% 3d) (-2.5% 7d) (Infinity% volume)
Earnings Calendar: 2024-01-30
Market Cap: $ 43,403,273,060
http://www.johnsoncontrols.com
Sec Filling | Patents | 97000 employees

(IE) Johnson Controls International Plc engages in the provision of buildings products, energy solutions, integrated infrastructure and next generation transportation systems. Its technology and service capabilities include fire, security, HVAC, power solutions and energy storage to serve various end markets including large institutions, commercial buildings, retail, industrial, small business and residential. The company was established in 1885 and is headquartered in Cork, Ireland.

energy security bhvac

add to watch list Paper trade email alert is off

Perrigo Company

PRGO | $30.04 0.27% 0.0% 780K

Health Technology

(0.0% 1d) (-0.7% 1m) (-17.1% 1y) (0.0% 2d) (0.3% 3d) (-0.9% 7d) (-46.44% volume)
Earnings Calendar:
Market Cap: $ 4,070,898,808
http://www.perrigo.com
Sec Filling | Patents | 11200 employees

(IE) Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The firm operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the U.S., Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with consumer-focused businesses in the U.K. and Australia. The Prescription Pharmaceuticals commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

israel brands diagnostics